Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads
French drug company Sanofi-Aventis (SNY) Thursday said it has completed the acquisition of 100% of Chattem, Inc. (CHTT), which is now a...
SCHEDULE 13G Amendment No. 5 Chattem, Inc. Common Stock Cusip #162456107 Cusip #162456107 Item 1: Reporting Person - FMR LLC Item 4:...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...
Chattem, Inc. (NASDAQ: CHTT) (“Chattem”) announced that it has commenced a tender offer (the “Tender Offer”) to repurchase all of...
As previously reported on Chattem, Inc.'s (NASDAQ: CHTT) (the “Company”) Form 8-K filed on February 12, 2010 (the “Form 8-K”...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities...
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0101 Washington, D.C. 20549 Expires: March 31, 2011...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.